PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Abstract
Authors
W Chen
W Chen
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now